| 1. | In the hospital authority ( ha ) context , vioxx belongs to category cox - ii drugs and it is not a standard drug item in the ha formulary
医院管理局（医管局）把快确适列为cox - ii类别药物，此药并非公立医院的常规药物。 |
| 2. | The manufacturer started visiting hospitals , dispensaries and private doctors who have been supplied with vioxx to facilitate latter s surrender of the drug
同时，制造商开始到访曾获供应快确适的医院、药房和私家医生，以便他们退回药物。 |
| 3. | & ( b ) since the manufacturer s public notification of a voluntary recall of vioxx , the department of health ( dh ) has been closely monitoring the progress of the recall
（一）及（二）自从制造商宣布主动回收快确适后， ?生署一直密切监察事态的发展。 |
| 4. | The us manufacturer of the drug initiated a worldwide recall of the product based on the results of a recent study on the side effects arising from prolonged use ( over 18 months ) of the drug
该药的美国制造商基于最近一项对长期（超过十八个月）服用快确适所引致的副作用的研究结果，决定对该药展开全球性的回收行动。 |
| 5. | It has been reported that an analgesic drug known as vioxx was earlier confirmed as increasing the risk of heart attack and stroke in users , thus leading to an extensive recall initiated by the drug company concerned
据报，一种名为快确适的止痛药早前被证实会增加服用者患上心脏病及中风的机会，有关药厂因而已主动全面回收该药物。 |
| 6. | It also notified all doctors , hospitals and dispensaries to which it had supplied vioxx about the recall in writing on october 2 - 4 , 2004 and advised them to follow - up with those patients who have been prescribed with the drug
在二四年十月二日至四日期间，制造商就回收行动以书面方式通知所有曾获供应快确适的医生、医院和药房，并请他们向曾获处方此药的病人进行跟进。 |
| 7. | In the public hospital context , as soon as the ha received the report on the total recall of vioxx , it notified its frontline staff by means of internal memo issued through cluster chief executives , hospital chief executives and heads of clinical departments
就公立医院而言，当医管局知悉制造商在市场全面回收快确适后，已立刻以内部备忘录方式，透过医院联网总监、医院行政总监及临床部门主管，向前线员工发放有关资讯。 |
| 8. | To supplement the issuance of the press release and the letter by the manufacturer to all doctors , hospitals and dispensaries to which it had supplied vioxx , dh also issued a follow - up press release as well as a letter to all registered doctors in hong kong in late october reminding them of the early return of this pharmaceutical product to the supplier and prescribe other suitable forms of medication to their patients
此外， ?生署亦在十月底发放新闻稿，并致函全港注册医生，提醒他们尽快把该药退回供应商，并向病人处方其他适当的药物，藉以补充制造商在十月初所发出的新闻稿，以及向曾获供应快确适的医生、医院和药房所发出的有关函件。 |
